5-(Carboethoxymethylidene)hydantoin-13C,15N2 is an intermediate formed in the synthesis of Orotic Acid-13C,15N2 Monohydrate, a labeled orotic acid, used in the preparation of therapeutic agents for chronic obstructive pulmonary disease (COPD) treatment.
Molecular Formula:C613CH815N2O4
Solubility:DMSO, hot ethanol
Molecular Weight:187.13
Storage and Stability:Store at -20°C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.